Literature DB >> 12482425

Novel inhibitors of neuronal nitric oxide synthase with potent antioxidant properties.

Serge Auvin1, Michel Auguet, Edith Navet, Jeremiah J Harnett, Isabelle Viossat, Jocelyne Schulz, Dennis Bigg, Pierre E Chabrier.   

Abstract

A series of hybrid compounds possessing an nNOS pharmacophore linked to an antioxidant fragment has been synthesized. Among them, compound 8d, a propofol derivative, displayed the greatest dual potencies against nNOS (IC(50)=0.12 microM) and lipid peroxidation (IC(50)=0.4 microM) accompanied with e/nNOS selectivity (67.5). This shows that nNOS was able to accommodate very bulky groups such as di-tert-butyl or di-iso-propyl phenol in its active site.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482425     DOI: 10.1016/s0960-894x(02)00883-1

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Mitochondrial targeting of radioprotectants using peptidyl conjugates.

Authors:  Anthony Kanai; Irina Zabbarova; Andrew Amoscato; Michael Epperly; Jingbo Xiao; Peter Wipf
Journal:  Org Biomol Chem       Date:  2006-12-07       Impact factor: 3.876

Review 2.  Development of nitric oxide synthase inhibitors for neurodegeneration and neuropathic pain.

Authors:  Paramita Mukherjee; Maris A Cinelli; Soosung Kang; Richard B Silverman
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

Review 3.  Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.

Authors:  He Huang; Richard B Silverman
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

4.  Protective action of a hexane crude extract of Pterodon emarginatus fruits against oxidative and nitrosative stress induced by acute exercise in rats.

Authors:  Fernanda B A Paula; Cibele M C P Gouvêa; Patrícia P Alfredo; Ione Salgado
Journal:  BMC Complement Altern Med       Date:  2005-08-17       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.